HTG Molecular Diagnostics to Announce Year End 2021 Financial Results and Host Conference Call on Tuesday, March 29
HTG Molecular Diagnostics (Nasdaq: HTGM) announces it will report its financial results for the fiscal year ended December 31, 2021, on March 29, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
HTG Molecular Diagnostics (Nasdaq: HTGM) announces it will report its financial results for the fiscal year ended December 31, 2021, on March 29, 2022, after market close. A conference call with investors is scheduled for the same day at 4:30 PM ET to discuss the results and provide corporate updates. HTG focuses on advancing precision medicine through its innovative transcriptome profiling technology, enhancing the development of life science tools and clinical diagnostics.
Positive
- HTG is advancing precision medicine, which could enhance market potential.
- The upcoming financial results announcement may provide insights into company performance.
Negative
- None.
Details
News Market Reaction – HTGM
The recorded move for HTGM in the trading session of this news was -3.57%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TUCSON, Ariz., March 22, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the year ended December 31, 2021 after the market close on Tuesday, March 29, 2022.
Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Details for the conference call are as follows:
| Conference Call & Webcast Details | |
| Date: | Tuesday, March 29 |
| Time: | 4:30pm ET |
| Toll Free: | 1-855-327-6837 |
| International: | 1-631-891-4304 |
| Conference ID: | 10018508 |
| Webcast: | https://themediaframe.com/mediaframe/webcast.html?webcastid=pSgvu2PM |
About HTG:
HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.
Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG’s proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery. For more information visit www.htgmolecular.com.
HTG Investor Contact:
Ashley Robinson
LifeSci Advisors
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.